60 DEGREES PHARMACEUTICALS LLC has a total of 14 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, environmental technology and organic fine chemistry are SOUYAKU GIJUTSU KENKYUSHO KK, UNIV FED DO PARA and ROSSIGNOL JEAN FRANCOIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 2 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Singapore | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Climate change adaptation technologies | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Dow Geoffrey S | 12 |
#2 | Smith Bryan L | 8 |
#3 | Jones John Paul | 6 |
#4 | Schmuklarsky Moshe | 6 |
#5 | Budda Balasubrahmanyan | 6 |
#6 | Low Jenny | 5 |
#7 | Watanabe Satoru | 5 |
#8 | Vasudevan Subhash | 5 |
#9 | Ooi Eng Eong | 5 |
#10 | Reid Mark | 4 |
Publication | Filing date | Title |
---|---|---|
US2018360809A1 | Novel Dosing Regimens of Celgosivir For The Prevention of Dengue | |
EP3212621A1 | Novel regimens of tafenoquine for prevention of malaria in malaria-naïve subjects | |
US2016030403A1 | Dosing regimens of celgosivir for the treatment of dengue |